Replies to post #156943 on Avid Bioservices Inc (CDMO)

[asmarterwookie]

Thanks bio...From Paul.."We are "uniquely" positioned with our later stage pipeline of first-in-class therapeutics..."

Is Cotara first in class as well?
I still say the "we" keep it.
Great Life Saving Potential, unique, HIGH $ paid by insurance(orphan status), Notoriety/Marketing Impact..WE MAKE IT....

Enjoy the weekend all....

wook

[dia76ca]

Will there be Bavi/anti-PD-1 data released January 30? The summary of the Jan.30 presentation includes the following...

" Using multiple tumor models in mice, we demonstrate PS targeting antibodies enhance the anti-tumor activity of multiple forms of therapy including anti-CTLA-4 and anti-PD-1 checkpoint inhibitor antibodies."

We have already seen some of the data from the Bavi/Yervoy combination. However we have not yet seen any Bavi/anti-PD-1 data. This should be interesting.

[horselover45]

We all seem to have our prerogatives.

The one conference that I would like to listen to is the Jan 29th by Steve Demattos,

Global multi-site trial to ensure efficient trial control.

With all the crap that has happened to our trials these past couple of years would def feel better if that scenario is past history not ever to repeat.

Andy C..